News | Radiation Dose Management | February 28, 2017

ACR Updates Guidelines for NEMA XR-29 CT Dose Standard

Document states Medic Vision’s SafeCT-29 is the only FDA- and CMS-approved third-party vendor XR-29 upgrade product

ACR, guideline update, NEMA XR-29 Smart Dose Standard, Medic Vision, SafeCT-29

February 28, 2017 — The American College of Radiology (ACR) published updated guidelines regarding the NEMA XR-29 (MITA Smart Dose) Standard, finally setting a clear and specific set of guidelines for an acceptable Certificate of NEMA XR-29 Compliance. The publication specifically declares, "certificates of NEMA XR-29 Compliance from third-party vendors are acceptable if: (1) The third-party vendor has obtained the required FDA [U.S. Food and Drug Administration] 510(K) pre-market clearance for their upgrade product; and (2) The third-party vendor upgrade product has been approved by CMS [Centers for Medicare and Medicaid Services]."

Furthermore, the document states, "Currently, the only FDA- and CMS-approved third-party vendor NEMA XR-29 upgrade product is the Medic Vision SafeCT-29."

The SafeCT-29 system is an add-on system that helps achieve compliance with the XR-29 Standard for computed tomography (CT) and positron emission tomography (PET)/CT systems equipped with automatic exposure control (AEC) and Reference protocols. SafeCT-29 provides the XR-29 Dose Check and RDSR functions. It is the first and only FDA 510k-cleared third-party solution on the market, according to Medic vision.

The timing of this guideline announcement is critical, according to Medic Vision, as CMS penalties for non-compliance triple this year. Health institutes that did not receive OEM support for XR-29 compliance and did not purchase SafeCT-29 as a third-party FDA-cleared solution for CT and PET/CT scanners, may now have to start over and potentially be subject to the 15 percent CMS penalty, which went into effect on Jan. 1, 2017.

For more information: www.medicvision.com

Related Content

News | Computed Tomography (CT)

August 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the combination of deep-learning ...

Home August 15, 2022
Home
News | Computed Tomography (CT)

June 16, 2022 — Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly ...

Home June 16, 2022
Home
News | Computed Tomography (CT)

June 15, 2022 — Seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography ...

Home June 15, 2022
Home
News | Computed Tomography (CT)
March 29, 2022 – Cardiac computed tomography (CCT) is an accurate, noninvasive diagnostic test for obstructive coronary ...
Home March 29, 2022
Home
News | Computed Tomography (CT)
March 11, 2022 – Is cardiac computed tomography (CT) as reliable as catheterization in patients with suspected coronary ...
Home March 11, 2022
Home
News | Computed Tomography (CT)

January 31, 2022 — Lee Health’s Gulf Coast Medical Center in Fort Myers, Fla., recently became the first U.S. healthcare ...

Home January 31, 2022
Home
News | Computed Tomography (CT)

October 20, 2021 — HeartFlow Inc. announced the commencement of the REVEALPLAQUE (A pRospEctiVe, multicEnter study to ...

Home October 20, 2021
Home
News | Computed Tomography (CT)

October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves ...

Home October 14, 2021
Home
Feature | Computed Tomography (CT)

October 6, 2021 — Data presented during the late-breaking science session at the European Society of Cardiology (ESC) ...

Home October 06, 2021
Home
Feature | Computed Tomography (CT) | By Dave Fornell, DAIC Editor

The U.S. Food and Drug Administration (FDA) Sept. 30 cleared the world's first photon-counting computed tomography (CT) ...

Home October 04, 2021
Home
Subscribe Now